跳至主要内容
临床试验/NCT02426164
NCT02426164撤回4 期

Analgesic Efficacy of Liposomal Bupivacaine in Total Knee Arthroplasty

Miller Orthopedic Specialists1 个研究点 分布在 1 个国家开始时间: 2015年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
撤回
试验地点
1
主要终点
Mean visual analog scale (VAS) pain scores

研究概览

简要总结

Liposomal bupivacaine is a novel local anesthetic designed for prolonged pain relief. Despite its long-acting analgesic potential, liposomal bupivacaine is significantly more expensive than other local anesthetic alternatives. The primary aim of this investigation is to examine whether or not liposomal bupivacaine provides superior pain relief or clinically significant opioid-sparing effects versus a control to justify its cost.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing a primary unilateral total knee arthroplasty by the PI of the trial

排除标准

  • Patients with a sensitivity to marcaine
  • Pregnant or lactating women
  • Non-English speaking individuals

研究组 & 干预措施

Liposomal bupivacaine

Active Comparator

Periarticular infiltration of 20cc of liposomal bupivacaine with 20cc of normal saline administered prior to cementation of knee implants

干预措施: Liposomal bupivacaine (Drug)

bupivacaine HCl, morphine, epinephrine, methylprednisolone

Active Comparator

Periarticular infiltration of 24c of bupivacaine HCl, 0.8cc morphine, 0.3cc epinephrine, and 1cc of methylprednisolone administered prior to cementation of knee implants

干预措施: bupivacaine HCl, morphine, epinephrine, methylprednisolone (Drug)

结局指标

主要结局

Mean visual analog scale (VAS) pain scores

时间窗: Post-operative day 2

Self-reported pain scores from 0=no pain to 10=severe pain

Pain assessment phone call

时间窗: Post-operative day 3

Subjects will be called on post-operative day three by one of the investigators of the study. Subjects will be asked to rate their current pain level from 1 to 10 and to rate their worst pain level from 1 to 10 that day.

次要结局

  • Complications(Complications will be followed for the duration of patients' hospital stay, an expected average of 2-3 days.)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验